BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 30047411)

  • 21. Clinical spectrum and clonal evolution in germline syndromes with predisposition to myeloid neoplasms.
    Perez Botero J; Ho TP; Hogan WJ; Kenderian S; Gangat N; Tefferi A; Abraham RS; Nguyen P; Oliveira JL; He R; Chen D; Viswanatha D; Rodriguez V; Khan SP; Patnaik MM
    Br J Haematol; 2018 Jul; 182(1):141-145. PubMed ID: 28485484
    [No Abstract]   [Full Text] [Related]  

  • 22. Inherited bone marrow failure syndromes: considerations pre- and posttransplant.
    Alter BP
    Blood; 2017 Nov; 130(21):2257-2264. PubMed ID: 29167174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aplastic anemia and clonal evolution: germ line and somatic genetics.
    Shimamura A
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):74-82. PubMed ID: 27913465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The small population of PIG-A mutant cells in myelodysplastic syndromes do not arise from multipotent hematopoietic stem cells.
    Pu JJ; Hu R; Mukhina GL; Carraway HE; McDevitt MA; Brodsky RA
    Haematologica; 2012 Aug; 97(8):1225-33. PubMed ID: 22315493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Function and malfunction of hematopoietic stem cells in primary bone marrow failure syndromes.
    Risitano AM; Maciejewski JP; Selleri C; Rotoli B
    Curr Stem Cell Res Ther; 2007 Jan; 2(1):39-52. PubMed ID: 18220891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes.
    Hoffman H; Rice C; Skordalakes E
    J Biol Chem; 2017 Mar; 292(11):4593-4601. PubMed ID: 28154186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Refractory anemia with ring sideroblasts.
    Malcovati L; Cazzola M
    Best Pract Res Clin Haematol; 2013 Dec; 26(4):377-85. PubMed ID: 24507814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between idiopathic cytopenias/dysplasias of uncertain significance (ICUS/IDUS) and autoimmunity.
    Barcellini W
    Expert Rev Hematol; 2017 Jul; 10(7):649-657. PubMed ID: 28586251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inherited bone marrow failure syndromes.
    Collins J; Dokal I
    Hematology; 2015 Aug; 20(7):433-4. PubMed ID: 26218202
    [No Abstract]   [Full Text] [Related]  

  • 30. Congenital hypoplastic bone marrow failure associated with a de novo partial deletion of the MECOM gene at 3q26.2.
    Kjeldsen E; Veigaard C; Aggerholm A; Hasle H
    Gene; 2018 May; 656():86-94. PubMed ID: 29496554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Shichishima T; Noji H
    Hematology; 2002 Aug; 7(4):211-27. PubMed ID: 14972783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure.
    Raza A; Ravandi F; Rastogi A; Bubis J; Lim SH; Weitz I; Castro-Malaspina H; Galili N; Jawde RA; Illingworth A
    Cytometry B Clin Cytom; 2014 May; 86(3):175-82. PubMed ID: 24227693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonal hematopoiesis in acquired aplastic anemia.
    Ogawa S
    Blood; 2016 Jul; 128(3):337-47. PubMed ID: 27121470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients.
    Keel SB; Scott A; Sanchez-Bonilla M; Ho PA; Gulsuner S; Pritchard CC; Abkowitz JL; King MC; Walsh T; Shimamura A
    Haematologica; 2016 Nov; 101(11):1343-1350. PubMed ID: 27418648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapamycin is highly effective in murine models of immune-mediated bone marrow failure.
    Feng X; Lin Z; Sun W; Hollinger MK; Desierto MJ; Keyvanfar K; Malide D; Muranski P; Chen J; Young NS
    Haematologica; 2017 Oct; 102(10):1691-1703. PubMed ID: 28729300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatic Mutations in Aplastic Anemia.
    Mufti GJ; Marsh JCW
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):595-607. PubMed ID: 30047413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of paroxysmal nocturnal hemoglobinuria clones to exclude inherited bone marrow failure syndromes.
    DeZern AE; Symons HJ; Resar LS; Borowitz MJ; Armanios MY; Brodsky RA
    Eur J Haematol; 2014 Jun; 92(6):467-70. PubMed ID: 24612308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the proliferating cell nuclear antigen in bone marrow cells from patients with myelodysplastic syndromes and aplastic anemia.
    Kitagawa M; Kamiyama R; Kasuga T
    Hum Pathol; 1993 Apr; 24(4):359-63. PubMed ID: 8098317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes.
    Ware RE; Pickens CV; DeCastro CM; Howard TA
    Exp Hematol; 2001 Dec; 29(12):1403-9. PubMed ID: 11750098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two cases showing clonal progression with full evolution from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome to myelodysplastic syndromes and leukemia.
    Ishihara S; Nakakuma H; Kawaguchi T; Nagakura S; Horikawa K; Hidaka M; Asou N; Mitsuya H
    Int J Hematol; 2000 Aug; 72(2):206-9. PubMed ID: 11039670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.